abstract |
The invention relates to the use of substances reducing cellular glutathione content for producing a medicament for treating T-cell mediated autoimmune diseases. The substances are selected from the group comprising L-BSO, ifosfamide, diethyl maleate, acetaminophen or other glutathione-S conjugating agents. |